Autoimmune Myocarditis and Arrhythmogenic Mitral Valve Prolapse: An Unexpected Overlap Syndrome.
Andrea VillatoreSimone SalaStefano StellaDavide VignaleElena BusnardoErnesto Di CesareCristina BassoPaolo Della BellaPatrizio MazzoneGiovanni PerettoPublished in: Journal of cardiovascular development and disease (2021)
in patients with recurrent VF episodes despite evidence-based medical treatment for myocarditis, MVP should be considered as an alternative arrhythmogenic substrate, and warrants early ICD implant and PVC-targeted therapy.